EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC 4.0

Systematic review and meta-analysis of the efficacy of benzodiazepines for dyspnea in patients with cancer

Shuntaro Yasuda iD, Koji Sugano, Yoshinobu Matsuda iD, Jun Kako, Yusuke Takagi, Hiroaki Watanabe, Yoko Kasahara, Sho Goya, Hiroyuki Kohara, Masanori Mori, Takeo Nakayama, Takashi Yamaguchi iD

Japanese Journal of Clinical Oncology · 30.03.2023 · 53 (4) · 327-334

DOI: 10.1093/jjco/hyac206 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Japanese Journal of Clinical Oncology, online erschienen am 12.01.2023. Verfasst von Shuntaro Yasuda und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Tokyo Medical and Dental University Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Benzodiazepines, Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective the role of benzodiazepines in relieving dyspnea in patients with cancer has not yet been established. This systematic review and meta-analysis aimed to determine the efficacy and safety of benzodiazepines alone or in combination with opioids for dyspnea in patients with cancer. Methods Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE and Ichushi-Web were searched for articles published from database inception to 23 September 2019. Studies of benzodiazepines alone or in combination with opioids for dyspnea were included. The primary outcome measure was the relief of dyspnea. The secondary outcome measures were anxiety, somnolence and severe adverse events. Results of 505 publications initially identified, two trials and one trial were included in the meta-analysis of midazolam alone and in combination with morphine, respectively. With regard to the relief of dyspnea, midazolam alone showed no significant difference compared with morphine alone, with a relative risk of 0.95 (95% confidence interval: 0.47–1.89). Meanwhile, midazolam plus morphine was significantly more effective than morphine alone, with a relative risk of 1.33 (95% confidence interval: 1.02–1.75). For anxiety relief, a meta-analysis could not be performed because of insufficient data. The incidence of somnolence and severe adverse events was not significantly different between the experimental and control groups for either midazolam alone or in combination with morphine. Conclusions benzodiazepines alone do not significantly improve dyspnea compared with opioids alone, but a combination of benzodiazepines and opioids may be more effective. Evidence from randomized controlled trials focusing on patients with cancer has not been generated in recent years. Further appropriately designed randomized controlled trials are required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzodiazepinesNeoplasmsHumansMidazolamSleepinessDyspneaMorphineAnalgesics, Opioid

Stichwörter der Autor:innen

MeSHopioidsbenzodiazepinescancerdyspneasystematic review

Substanzen

BenzodiazepinesMidazolamMorphineAnalgesics, Opioid

Autor:innen und Institutionen

  • Department of Pharmacy, Tokyo Medical and Dental University Hospital, Tokyo, Japan.
  • Division of Respiratory Medicine, Juntendo Tokyo Koto Geriatric Medical Center, Tokyo, Japan.
  • Department of Psychosomatic Internal Medicine, National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai, Japan.
  • College of Nursing Art and Science, University of Hyogo, Akashi, Japan.
  • Department of Palliative Medicine, Teikyo University School of Medicine Graduate School of Medicine, Tokyo, Japan.
  • Home Palliative Care Asunaro Clinic, Komaki, Japan.

ORCID-Profile: Shuntaro Yasuda, Yoshinobu Matsuda, Takashi Yamaguchi

Zitieren

APA

Yasuda, S., Sugano, K., Matsuda, Y., Kako, J., Takagi, Y., Watanabe, H., Kasahara, Y., Goya, S., Kohara, H., Mori, M., Nakayama, T., & Yamaguchi, T. (2023). Systematic review and meta-analysis of the efficacy of benzodiazepines for dyspnea in patients with cancer. Japanese Journal of Clinical Oncology, 53(4), 327-334. https://doi.org/10.1093/jjco/hyac206

Vancouver

Yasuda S, Sugano K, Matsuda Y, Kako J, Takagi Y, Watanabe H, et al. Systematic review and meta-analysis of the efficacy of benzodiazepines for dyspnea in patients with cancer. Japanese Journal of Clinical Oncology. 2023;53(4):327-334. doi:10.1093/jjco/hyac206

BibTeX
@article{Yasuda2023,
  author = {Yasuda, Shuntaro and Sugano, Koji and Matsuda, Yoshinobu and Kako, Jun and Takagi, Yusuke and Watanabe, Hiroaki and Kasahara, Yoko and Goya, Sho and Kohara, Hiroyuki and Mori, Masanori and Nakayama, Takeo and Yamaguchi, Takashi},
  title = {Systematic review and meta-analysis of the efficacy of benzodiazepines for dyspnea in patients with cancer},
  journal = {Japanese Journal of Clinical Oncology},
  year = {2023},
  volume = {53},
  number = {4},
  pages = {327--334},
  doi = {10.1093/jjco/hyac206}
}
Kostenlos starten →